Maze Therapeutics, Inc. (MAZE)
NASDAQ: MAZE · Real-Time Price · USD
35.45
+0.54 (1.55%)
At close: Nov 10, 2026, 4:00 PM EST
36.56
+1.11 (3.13%)
Pre-market: Nov 11, 2026, 7:37 AM EST
Maze Therapeutics Employees
Maze Therapeutics had 141 employees as of December 31, 2025. The number of employees increased by 16 or 12.80% compared to the previous year. That makes Maze Therapeutics the 29,276th largest employer in the world and 3,707th in the United States.
Employees
141
Change (1Y)
16
Growth (1Y)
12.80%
Revenue / Employee
$141,844
Profits / Employee
-$1,074,270
Market Cap
1.94B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 141 | 16 | 12.80% |
| Dec 31, 2024 | 125 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Sarepta Therapeutics | 835 |
| Novavax | 749 |
| Agios Pharmaceuticals | 540 |
| Maravai LifeSciences Holdings | 410 |
| Harmony Biosciences Holdings | 293 |
| Stoke Therapeutics | 170 |
| Zenas BioPharma | 167 |
| Absci | 140 |
MAZE News
- 38 minutes ago - Maze Therapeutics price target lowered to $51 from $53 at JPMorgan - TheFly
- 18 hours ago - Maze Therapeutics Transcript: 3rd Annual Guggenheim Healthcare Innovation Conference - Transcripts
- 19 hours ago - Maze Therapeutics reports Q3 EPS (79c), consensus (75c) - TheFly
- 19 hours ago - Maze Therapeutics completes enrollment in Phase 2 HORIZON trial - TheFly
- 1 day ago - Maze Therapeutics Reports Third Quarter 2026 Financial Results and Recent Highlights - GlobeNewsWire
- 1 day ago - Maze Therapeutics Earnings release: Q3 2026 - Filings
- 1 day ago - Maze Therapeutics Quarterly report: Q3 2026 - Filings
- 8 days ago - Maze Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewsWire